Clearbridge Investments, LLC Intra Cellular Therapies, Inc. Transaction History
Clearbridge Investments, LLC
- $119 Billion
- Q4 2024
A detailed history of Clearbridge Investments, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Clearbridge Investments, LLC holds 1,686,384 shares of ITCI stock, worth $221 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
1,686,384
Previous 1,729,729
2.51%
Holding current value
$221 Million
Previous $126 Million
11.36%
% of portfolio
0.12%
Previous 0.1%
Shares
22 transactions
Others Institutions Holding ITCI
# of Institutions
418Shares Held
88.6MCall Options Held
284KPut Options Held
105K-
Vanguard Group Inc Valley Forge, PA9.72MShares$1.28 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$829 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.13MShares$672 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$426 Million1.36% of portfolio
-
Norges Bank Oslo, Q83.21MShares$422 Million0.04% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.4B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...